Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Recruiting 19Active not recruiting 19Completed 16Terminated 3Suspended 2Withdrawn 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasms 18Breast Neoplasms 16Leukemia, Myeloid, Acute 15Glioblastoma 13Colorectal Neoplasms 13Prostatic Neoplasms 12Neoplasm Metastasis 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Lung Neoplasms 9Glioma 8Carcinoma, Hepatocellular 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Head and Neck Neoplasms 7Carcinoma, Renal Cell 7Ovarian Neoplasms 6Myelodysplastic Syndromes 6Hematologic Neoplasms 6Triple Negative Breast Neoplasms 5Rectal Neoplasms 5Melanoma 5Uterine Cervical Neoplasms 4Sarcoma 4Colonic Neoplasms 4Brain Neoplasms 4Solid Tumor 3Small Cell Lung Carcinoma 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

exemestane 1Tamoxifen 1Magnetic Resonance Spectroscopy 1Letrozole 1Anastrozole 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Breast Carcinoma In Situ × 1 year × Clear all
NCT06671912 2026-06-02

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended
1,156 enrolled
Breast

Breast Carcinoma In Situ

NCT03077841 2026-03-05

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

M.D. Anderson Cancer Center

Phase 2/3 Suspended
928 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡